![](https://investorshub.advfn.com/uicon/60294.png?cb=1611719355)
Monday, March 05, 2018 12:57:15 AM
Of course the Sackler family aka Purdue will be well prepared with Mundipharma. What they loose through the competition with generic OxyContin in the US will be supplemented through sales of OxyContin in countries where there are no restrictions.
More than likely the US based Purdue may start having a harder time, but overall the business for the Sacklers won't break a sweat. They'll just keep pumping their addictive/easily abused Oxy out to other countries under Mundipharma.
What I find interesting is if Elite forms a partnership/JV with PuraCap/HumanWell to sell OxyContin in China. That will also mean competition for Mundipharma in a market Mundi would love to have. China, Mexico, SE Asia, all part of Mundi's strategy (from the Esquire article).
Some interesting stuff coming in the near future.
Companies like Elite could really waffle Purdue's US business though.
When a company builds a better generic mouse trap. that not only works as well, but is cheaper and insurance companies will back..... just stands to reason. Some hurt is gonna come round. Plus SequestOx will also put a dent in Purdue's Oxy since their Oxy is a tweener anyway.
Only gives 8-10 hours of extended relief, not the 12 Purdue claims.
Yep Purdue was top dog..... not for long though. JMO
Really looking forward to Purdue taking some revenue hits.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM